‘Room for improvement’: Treating ankylosing spondylitis

Ankylosing spondylitis presents significant challenges in pain management and remains a controversial topic with limited data for efficacy.

Current guidelines for rheumatologists suggest biologic tumor necrosis factor and interleukin 17 (IL-17) inhibitors, disease-modifying antirheumatic drugs (DMARDs) like sulfasalazine, and antirheumatic treatments with NSAIDs to relieve pain and stiffness. But those […]

Click here to view original web page at www.healio.com

Leave a Reply

%d bloggers like this: